Literature DB >> 17056394

Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.

Nick C Patel1, Melissa P DelBello, Kim M Cecil, Caleb M Adler, Holly S Bryan, Kevin E Stanford, Stephen M Strakowski.   

Abstract

BACKGROUND: The neurochemical effects of lithium in adolescents with bipolar disorder largely are unknown. This study used proton magnetic resonance spectroscopy (1H MRS) to identify the in vivo effects of lithium on myo-inositol (mI) concentrations in adolescent bipolar depression.
METHODS: Twenty-eight adolescents (12-18 years old) with bipolar I disorder, current episode depressed, received open-label lithium 30 mg/kg, adjusted to achieve serum levels of 1.0-1.2 mEq/L. The mI concentrations in the medial as well as the left and right lateral prefrontal cortices were measured at baseline, day 7, and day 42 of treatment. Changes in mI concentrations over time were analyzed.
RESULTS: Significant main effects of time were observed for mI concentrations in the medial (p = .03) and right lateral (p = .05) prefrontal cortices. Baseline concentrations of mI were not significantly different from day 7 or day 42 concentrations. However, mI concentrations on day 42 were significantly higher than those on day 7 (p = .02) in both regions.
CONCLUSIONS: This study demonstrates that prefrontal mI concentrations do not significantly change from baseline after acute and chronic lithium treatment in adolescents with bipolar depression. Further investigation of the effect of lithium on mI is warranted to better understand possible mechanisms by which lithium exerts antidepressant activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056394      PMCID: PMC1761698          DOI: 10.1016/j.biopsych.2006.07.029

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  37 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

Authors:  M K Spearing; R M Post; G S Leverich; D Brandt; W Nolen
Journal:  Psychiatry Res       Date:  1997-12-05       Impact factor: 3.222

Review 3.  Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.

Authors:  Peter H Silverstone; Brent M McGrath; Hyeonjin Kim
Journal:  Bipolar Disord       Date:  2005-02       Impact factor: 6.744

Review 4.  The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling.

Authors:  M J Berridge
Journal:  JAMA       Date:  1989-10-06       Impact factor: 56.272

5.  Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder.

Authors:  P Davanzo; M A Thomas; K Yue; T Oshiro; T Belin; M Strober; J McCracken
Journal:  Neuropsychopharmacology       Date:  2001-04       Impact factor: 7.853

6.  Medication use in children and adolescents treated in the community for bipolar disorder.

Authors:  Robinder K Bhangoo; Catherine H Lowe; Frances S Myers; Julia Treland; Justin Curran; Kenneth E Towbin; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

7.  Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.

Authors:  Latha K Parthasarathy; Ratnam S Seelan; Mark A Wilson; Robert E Vadnal; Ranga N Parthasarathy
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-02       Impact factor: 5.067

8.  Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy.

Authors:  Kim M Cecil; Melissa P DelBello; Rachel Morey; Stephen M Strakowski
Journal:  Bipolar Disord       Date:  2002-12       Impact factor: 6.744

9.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

10.  Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.

Authors:  Pablo Davanzo; Kenneth Yue; M Albert Thomas; Thomas Belin; Jim Mintz; T N Venkatraman; Eliana Santoro; Sarah Barnett; James McCracken
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112

View more
  17 in total

1.  Prospective neurochemical characterization of child offspring of parents with bipolar disorder.

Authors:  Manpreet K Singh; Booil Jo; Nancy E Adleman; Meghan Howe; Layla Bararpour; Ryan G Kelley; Daniel Spielman; Kiki D Chang
Journal:  Psychiatry Res       Date:  2013-09-09       Impact factor: 3.222

2.  Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Eun-Kee Jeong; Rebekah S Huber; Perry F Renshaw
Journal:  Bipolar Disord       Date:  2012-07-20       Impact factor: 6.744

3.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

Review 4.  A review of MR spectroscopy studies of pediatric bipolar disorder.

Authors:  D G Kondo; T L Hellem; X-F Shi; Y H Sung; A P Prescot; T S Kim; R S Huber; L N Forrest; P F Renshaw
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-20       Impact factor: 3.825

5.  Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression.

Authors:  Kiki Chang; Melissa Delbello; Wen-Jang Chu; Amy Garrett; Ryan Kelley; Neil Mills; Meghan Howe; Holly Bryan; Cal Adler; Jim Eliassen; Daniel Spielman; Stephen M Strakowski
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-07-31       Impact factor: 2.576

Review 6.  The neural effects of psychotropic medications in children and adolescents.

Authors:  Manpreet K Singh; Kiki D Chang
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-10

Review 7.  Biologic basis of bipolar disorder in children and adolescents.

Authors:  Angelica Kloos; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

8.  Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.

Authors:  Nick C Patel; Kim M Cecil; Stephen M Strakowski; Caleb M Adler; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-12       Impact factor: 2.576

9.  N-acetyl aspartate levels in adolescents with bipolar and/or cannabis use disorders.

Authors:  Samantha M Bitter; Wade A Weber; Wen-Jang Chu; Caleb M Adler; James C Eliassen; Stephen M Strakowski; Melissa P DelBello
Journal:  J Dual Diagn       Date:  2014

10.  Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.

Authors:  Brent P Forester; Chelsea T Finn; Yosef A Berlow; Megan Wardrop; Perry F Renshaw; Constance M Moore
Journal:  Bipolar Disord       Date:  2008-09       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.